Escherichia coli Nissle 1917 Distinctively Modulates T-Cell Cycling and Expansion via Toll-Like Receptor 2 Signaling

Department of Hepatology and Gastroenterology, Campus Virchow Clinic, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany.
Infection and Immunity (Impact Factor: 3.73). 04/2005; 73(3):1452-65. DOI: 10.1128/IAI.73.3.1452-1465.2005
Source: PubMed


Although the probiotic Escherichia coli strain Nissle 1917 has been proven to be efficacious for the treatment of inflammatory bowel diseases, the underlying mechanisms
of action still remain elusive. The aim of the present study was to analyze the effects of E. coli Nissle 1917 on cell cycling and apoptosis of peripheral blood and lamina propria T cells (PBT and LPT, respectively). Anti-CD3-stimulated
PBT and LPT were treated with E. coli Nissle 1917-conditioned medium (E. coli Nissle 1917-CM) or heat-inactivated E. coli Nissle 1917. Cyclin B1, DNA content, and caspase 3 expression were measured by flow cytometry to assess cell cycle kinetics
and apoptosis. Protein levels of several cell cycle and apoptosis modulators were determined by immunoblotting, and cytokine
profiles were determined by cytometric bead array. E. coli Nissle 1917-CM inhibits cell cycling and expansion of peripheral blood but not mucosal T cells. Bacterial lipoproteins mimicked
the effect of E. coli Nissle 1917-CM; in contrast, heat-inactivated E. coli Nissle 1917, lipopolysaccharide, or CpG DNA did not alter PBT cell cycling. E. coli Nissle 1917-CM decreased cyclin D2, B1, and retinoblastoma protein expression, contributing to the reduction of T-cell proliferation.
E. coli Nissle 1917 significantly inhibited the expression of interleukin-2 (IL-2), tumor necrosis factor α, and gamma interferon
but increased IL-10 production in PBT. Using Toll-like receptor 2 (TLR-2) knockout mice, we further demonstrate that the inhibition
of PBT proliferation by E. coli Nissle 1917-CM is TLR-2 dependent. The differential reaction of circulating and tissue-bound T cells towards E. coli Nissle 1917 may explain the beneficial effect of E. coli Nissle 1917 in intestinal inflammation. E. coli Nissle 1917 may downregulate the expansion of newly recruited T cells into the mucosa and limit intestinal inflammation,
while already activated tissue-bound T cells may eliminate deleterious antigens in order to maintain immunological homeostasis.

Download full-text


Available from: Ralf R Schumann, Apr 27, 2015
    • "The main two genera of microorganisms indicated as sources of probiotic strains are Lactobacillus and Bifidobacterium. Some species of genera Lactococcus, Enterococcus, Saccharomyces, Streptococcus, Escherichia, Microbes 4(2) Bacillus, Leuconostoc and Propionibacterium were also recognised for their health benefits (Prado et al., 2008b; Sturm et al., 2005). Since many species of Bifidobacterium are found in the human GI tract, they were the first to be screened for probiotic functionality, safety and food application (Ventura et al., 2004). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit to the host. The two main genera of microorganisms indicated as sources of probiotic bacteria are Lactobacillus and Bifidobacterium. Historically used to produce fermented dairy products, certain strains of both genera are increasingly utilised to formulate other functional foods. As the consumers' understanding of the role of probiotics in health grows, so does the popularity of food containing them. The result of this phenomenon is an increase in the number of probiotic foods available for public consumption, including a rapidly-emerging variety of probiotic-containing non-dairy beverages, which provide a convenient way to improve and maintain health. However, the composition of non-dairy probiotic beverages can pose specific challenges to the survival of the health conferring microorganisms. To overcome these challenges, strain selection and protection techniques play an integral part in formulating a stable product. This review discusses non-dairy probiotic beverages, characteristics of an optimal beverage, and commonly used probiotic strains, including spore-forming bacteria. It also examines the most recent developments in probiotic encapsulation technology with focus on nano-fibre formation as a means of protecting viable cells. Utilising bacteria's natural armour or creating barrier mechanisms via encapsulation technology will fuel development of stable non-dairy probiotic beverages.
    No preview · Article · Dec 2012 · Beneficial Microbes
  • Source
    • "Our findings indicating role for HO-1 in Foxp3 induction but not in suppression of inflammatory cytokine production by CD4+ T cells contrasts those of Moreau et al [23] which suggested that, in vitro, HO-1 activity of DC does not play a role in the stimulation and expansion of Treg in vitro but instead directly inhibits T cell proliferation. However there are a number of in vivo studies that clearly support a role for HO-1 in promoting Foxp3+ Treg, [28], [47], [48] for example Xia et al showed that HO-1 activity is required for up-regulation of Foxp3+ Treg and subsequent attenuation of ovalbumin induced airway inflammation induced by the heme oxygenase activator, hemin [49]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We investigated the consequences of feeding with a Lactobacillus species on the immune environment in GALT, and the role of dendritic cells and heme oxygenase-1 in mediating these responses. Feeding with a specific strain of Lactobacillus rhamnosus induced a significant increase in CD4+CD25+Foxp3+ functional regulatory T cells in GALT. This increase was greatest in the mesenteric lymph nodes and associated with a marked decrease in TNF and IFNγ production. Dendritic cell regulatory function and HO-1 expression was also increased. The increase in Foxp3+ T cells could be prevented by treatment with a heme oxygenase inhibitor. However, neither inhibition of heme oxygenase nor blockade of IL-10 and TGFβ prevented the inhibition of inflammatory cytokine production. In conclusion Lactobacillus feeding induced a tolerogenic environment in GALT. HO-1 was critical to the enhancement of Foxp3+ regulatory T cells while additional, as yet unknown, pathways were involved in the down-regulation of inflammatory cytokine production by T cells.
    Full-text · Article · Oct 2012 · PLoS ONE
  • Source
    • "In spite of this clinical evidence, our understanding of the biological processes involved in the beneficial effects of probiotics is still limited. Several mechanisms have been postulated to contribute to the anti-inflammatory effect of probiotics in the gut, including competitive exclusion of pathogens, production of antimicrobial agents and organic acids, enhancement of the epithelial barrier function, increase of mucosal IgA secretion, and modulation of lymphocyte and dendritic cell function [5]–[6]. Abnormalities of T cell function are recognized to play a central role in IBD pathogenesis [7]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Probiotics appear to be beneficial in inflammatory bowel disease, but their mechanism of action is incompletely understood. We investigated whether probiotic-derived sphingomyelinase mediates this beneficial effect. Neutral sphingomyelinase (NSMase) activity was measured in sonicates of the probiotic L. brevis (LB) and S. thermophilus (ST) and the non-probiotic E. coli (EC) and E. faecalis (EF). Lamina propria mononuclear cells (LPMC) were obtained from patients with Crohn's disease (CD) and Ulcerative Colitis (UC), and peripheral blood mononuclear cells (PBMC) from healthy volunteers, analysing LPMC and PBMC apoptosis susceptibility, reactive oxygen species (ROS) generation and JNK activation. In some experiments, sonicates were preincubated with GSH or GW4869, a specific NSMase inhibitor. NSMase activity of LB and ST was 10-fold that of EC and EF sonicates. LB and ST sonicates induced significantly more apoptosis of CD and UC than control LPMC, whereas EC and EF sonicates failed to induce apoptosis. Pre-stimulation with anti-CD3/CD28 induced a significant and time-dependent increase in LB-induced apoptosis of LPMC and PBMC. Exposure to LB sonicates resulted in JNK activation and ROS production by LPMC. NSMase activity of LB sonicates was completely abrogated by GW4869, causing a dose-dependent reduction of LB-induced apoptosis. LB and ST selectively induced immune cell apoptosis, an effect dependent on the degree of cell activation and mediated by bacterial NSMase. These results suggest that induction of immune cell apoptosis is a mechanism of action of some probiotics, and that NSMase-mediated ceramide generation contributes to the therapeutic effects of probiotics.
    Full-text · Article · Mar 2011 · PLoS ONE
Show more